Rationale: Rapidly progressive interstitial lung disease (RP-ILD) associated with anti-Melanoma Differentiation-Associated Gene 5 dermatomyositis (anti-MDA5 DM) is a rare but life-threatening condition despite aggressive immunosuppressive treatment. Here, IFIH1 is linked to interstitial lung disease.